Literature DB >> 20045044

Iontophoretic transport of charged macromolecules across human sclera.

Poonam Chopra1, Jinsong Hao, S Kevin Li.   

Abstract

The mechanisms of transscleral iontophoresis have been investigated previously with small molecules in rabbit sclera. The objective of the present study was to examine transscleral iontophoretic transport of charged macromolecules across excised human sclera. Passive and 2mA iontophoretic transport experiments were conducted in side-by-side diffusion cells with human sclera. The effects of iontophoresis upon transscleral transport of model permeants bovine serum albumin (BSA) and polystyrene sulfonic acid (PSS) as well as a model drug bevacizumab (BEV) were determined. Passive and iontophoretic transport experiments of tetraethylammonium (TEA) and salicylic acid (SA) and passive transport experiments of the macromolecules served as the controls. The results of iontophoresis enhanced transport of TEA and SA across human sclera were consistent with those in a previous rabbit sclera study. For the iontophoretic transport of macromolecules BSA and BEV, higher iontophoretic fluxes were observed in anodal iontophoresis as compared to passive and cathodal iontophoresis. This suggests the importance of electroosmosis. For the polyelectrolyte PSS, higher iontophoretic flux was observed in cathodal iontophoresis compared to anodal iontophoresis. Both electroosmosis and electrophoresis affected iontophoretic fluxes of the macromolecules; the relative contributions of electroosmosis and electrophoresis were a function of molecular size and charge of the macromolecules. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045044      PMCID: PMC2838613          DOI: 10.1016/j.ijpharm.2009.12.046

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  26 in total

Review 1.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

Review 2.  Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.

Authors:  Marvin E Myles; Donna M Neumann; James M Hill
Journal:  Adv Drug Deliv Rev       Date:  2005-11-28       Impact factor: 15.470

Review 3.  Iontophoresis: a non-invasive ocular drug delivery.

Authors:  Esther Eljarrat-Binstock; Abraham J Domb
Journal:  J Control Release       Date:  2005-12-15       Impact factor: 9.776

Review 4.  Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.

Authors:  Veli-Pekka Ranta; Arto Urtti
Journal:  Adv Drug Deliv Rev       Date:  2006-09-16       Impact factor: 15.470

Review 5.  Challenges and obstacles of ocular pharmacokinetics and drug delivery.

Authors:  Arto Urtti
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

6.  Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.

Authors:  Joseph Frucht-Pery; Frederik Raiskup; Hadas Mechoulam; Mervyn Shapiro; Esther Eljarrat-Binstock; Abraham Domb
Journal:  Cornea       Date:  2006-12       Impact factor: 2.651

7.  Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

Authors:  Stephan Michels; Philip J Rosenfeld; Carmen A Puliafito; Erin N Marcus; Anna S Venkatraman
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

8.  Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.

Authors:  S Kevin Li; Yanhui Zhang; Honggang Zhu; William I Higuchi; Henry S White
Journal:  J Pharm Sci       Date:  2005-04       Impact factor: 3.534

9.  Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration.

Authors:  J Mordenti; R A Cuthbertson; N Ferrara; K Thomsen; L Berleau; V Licko; P C Allen; C R Valverde; Y G Meng; D T Fei; K M Fourre; A M Ryan
Journal:  Toxicol Pathol       Date:  1999 Sep-Oct       Impact factor: 1.902

10.  Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.

Authors:  Esther Eljarrat-Binstock; Abraham J Domb; Faik Orucov; Joseph Frucht-Pery; Jacob Pe'er
Journal:  Curr Eye Res       Date:  2007 Jul-Aug       Impact factor: 2.424

View more
  15 in total

1.  Optimization of dexamethasone mixed nanomicellar formulation.

Authors:  Kishore Cholkar; Sudharshan Hariharan; Sriram Gunda; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

2.  Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.

Authors:  Sarah Molokhia; Kongnara Papangkorn; Charlotte Butler; John W Higuchi; Balbir Brar; Balamurali Ambati; S Kevin Li; William I Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2020-03-05       Impact factor: 2.671

3.  Influence of permeant lipophilicity on permeation across human sclera.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2010-08-24       Impact factor: 4.200

4.  Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis.

Authors:  S Kevin Li; Mark R Liddell; He Wen
Journal:  J Pharm Biomed Anal       Date:  2011-01-05       Impact factor: 3.935

5.  Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

Authors:  Kishore Cholkar; Sriram Gunda; Ravinder Earla; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-11-26       Impact factor: 3.246

6.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

7.  Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera.

Authors:  Poonam Chopra; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2012-11-13       Impact factor: 3.534

8.  Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2012-12-04       Impact factor: 3.534

9.  Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).

Authors:  Kishore Cholkar; Brian C Gilger; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-12-17       Impact factor: 5.875

10.  Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.

Authors:  Kishore Cholkar; Brian C Gilger; Ashim K Mitra
Journal:  Transl Vis Sci Technol       Date:  2015-05-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.